OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

Celsa, Ciro;Cabibbo, Giuseppe;Fulgenzi, Claudia;Scheiner, Bernhard;Battaglia, Salvatore;D'Alessio, Antonio;Manfredi, Giulia;Stefanini, Bernardo;Nishida, Naoshi;Galle, Peter R.;Schulze, Kornelius;Wege, Henning;Ciccia, Roberta;Hsu, Wei-Fan;Vivaldi, Caterina;Wietharn, Brooke;Lin, Po-Ting;Pirozzi, Angelo;Pressiani, Tiziana;Dalbeni, Andrea;Natola, Leonardo Antonio;Auriemma, Alessandra;Rigamonti, Cristina;Burlone, Michela Emma;Parisi, Alessandro;Huang, Yi-Hsiang;Lee, Pei-Chang;Ang, Celina;Marron, Thomas;Pinter, Matthias;Cheon, Jaekyung;Chon, Hong Jae;Phen, Samuel;Singal, Amit;Gampa, Anuhya;Pillai, Anjana;Thimme, Robert;Vogel, Arndt;Soror, Noha;Ulahannan, Susanna V.;Sharma, Rohini;Sacerdoti, David;Pirisi, Mario;Rimassa, Lorenza;Lin, Chun-yen;Saeed, Anwaar;Röhlen, Natascha;Masi, Gianluca;Schoenlein, Martin;von Felden, Johann;Kudo, Masatoshi;Cortellini, Alessio;Camma, Calogero;Pinato, David J.

2024-01-01